AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 132 filers reported holding AIMMUNE THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.62 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $13,379,000 | +1.4% | 800,624 | -12.5% | 0.00% | 0.0% |
| Q1 2020 | $13,191,000 | -84.2% | 914,759 | -63.3% | 0.00% | -82.4% |
| Q4 2019 | $83,479,000 | +50.4% | 2,494,133 | -5.9% | 0.02% | +30.8% |
| Q3 2019 | $55,510,000 | +47.5% | 2,650,869 | +46.7% | 0.01% | +62.5% |
| Q2 2019 | $37,628,000 | -6.3% | 1,807,272 | +0.6% | 0.01% | -11.1% |
| Q1 2019 | $40,151,000 | -9.8% | 1,796,481 | -3.5% | 0.01% | -18.2% |
| Q4 2018 | $44,514,000 | -2.3% | 1,860,951 | +11.4% | 0.01% | +10.0% |
| Q3 2018 | $45,567,000 | -8.3% | 1,670,334 | -9.6% | 0.01% | -9.1% |
| Q2 2018 | $49,697,000 | -24.3% | 1,848,145 | -10.3% | 0.01% | -26.7% |
| Q1 2018 | $65,608,000 | +4190.9% | 2,061,192 | +5001.6% | 0.02% | – |
| Q4 2017 | $1,529,000 | +499.6% | 40,403 | +292.3% | 0.00% | – |
| Q3 2017 | $255,000 | -99.5% | 10,298 | -99.6% | 0.00% | -100.0% |
| Q1 2017 | $50,339,000 | +687.7% | 2,316,553 | +641.2% | 0.01% | +500.0% |
| Q4 2016 | $6,391,000 | – | 312,530 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 3,300,797 | $90,046,000 | 33.32% |
| Aisling Capital LLC | 1,990,000 | $54,287,000 | 11.73% |
| Foresite Capital Management III, LLC | 801,240 | $21,858,000 | 4.82% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 189,857 | $5,181,000 | 4.12% |
| AlpInvest Partners B.V. | 38,943 | $1,062,000 | 2.27% |
| Eventide Asset Management | 1,739,000 | $47,440,000 | 1.74% |
| Palo Alto Investors LP | 1,381,759 | $37,694,000 | 1.52% |
| Sofinnova Investments, Inc. | 222,295 | $6,064,000 | 0.54% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 553,000 | $15,086,000 | 0.54% |
| EMERALD ADVISERS, LLC | 486,666 | $13,276,000 | 0.49% |